As a collaborative biostatistician, I have worked on various clinical studies where I advocated and actively applied more advantageous models, and multiple biomedical studies where I advocated for standardized analysis (e.g. quantifying westner blots, Oil Red O staining, and immunohistochemistry images) as well as more rigorous methods beyond widely-adopted analysis in biomedical studies (e.g. t-tests, change-score analysis, and ratio normalization). These advanced and rigorous methods have greatly helped bench scientists understand their data with reliable and reproducible evidence.
In this project, we have investigated the role of Angiopoietin-2 in adipose tissue in combating obesity.
We found that this link is only significant in females, both in mice and a large human subjects cohort.
Interestingly, serum levels of Angiopoietin-2 in pre-and post-menopausal women are also significantly different.
This led us to examine the role of estrogen in Angiopoietin-2 transcription regulation in adipocytes,
and indeed Angiopoietin-2 is upregulated by estradiol.